Login to Your Account

Juno raising up to $319M, opens new Seattle HQ

By Michael Fitzhugh
Staff Writer

Friday, September 22, 2017

Making hay while the sun shines on cellular therapies, Juno Therapeutics Inc. is raising up to $318.7 million in a public follow-on offering and concurrent private placement with its partner Celgene Corp.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription